The Potential of Human Umbilical Cord-Derived Mesenchymal Stem Cells as a Novel Cellular Therapy for Multiple Sclerosis

• Published in: Cell transplantation Vol. 23; no. 1_suppl; pp. 113 - 122
• Main Authors: Li, Jin-Feng, Zhang, Da-Jin, Geng, Tongchao, Chen, Lin, Huang, Hongyun, Yin, Hong-Lei, Zhang, Yu-Zhen, Lou, Ji-Yu, Cao, Bingzhen, Wang, Yun-Liang
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.01.2014; SAGE Publishing
• Subjects: Adult; Cytokines - blood; Female; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stromal Cells - cytology; Multiple Sclerosis - blood; Multiple Sclerosis - physiopathology; Multiple Sclerosis - therapy; Recurrence; Umbilical Cord - cytology; Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs); Stem cell transplantation; Th1 immunity: Th2 immunity; Multiple sclerosis (MS); Cytokine

Multiple sclerosis (MS) is a complex disease of neurological disability, affecting more than 300 out of every 1 million people in the world. The purpose of the study was to evaluate the therapeutic effects of human umbilical cord-derived mesenchymal stem cell (hUC-MSC) transplantation in MS patients...